Ponatinib CAS 943319-70-8

Mahsulot tavsifi:

Mahsulot nomi: Ponatinib CAS NO: 943319-70-8

Sinonimlar:

3-(2-(Imidazo[1,2-b]piridazin-3-il)etinil)-4-metil-N-(4-((4-metilpiperazin-1-il)metil)-3-(triflorometil) fenil) benzamid;

3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide;

Tashqi ko'rinishi: sariq kukun

Assay :≥99.0%

Zichlik: 1,292 g/sm3

Xavfsizlik ma'lumotlari:

HS Code: 29335990

Ponatinib (trade name Iclusig, previously AP24534) is an oral drug developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors.

Ponatinib (AP24534) yangi kuchli, og'iz orqali qabul qilinadigan kichik molekulali ko'p maqsadli kinaz inhibitori. Ponatinib ham mahalliy, ham mutant BCR-ABLni inhibe qiladi. Ponatinib surunkali miyeloid leykemiyani (CML) BCR-ABL kinaz inhibitörleri bilan davolashda qo'llaniladi.

Mahsulotlarimiz bilan qiziqsangiz yoki savollaringiz bo'lsa, biz bilan bog'laning!

Patent ostidagi mahsulotlar R& uchun taklif etiladi; D faqat maqsad. Biroq, yakuniy javobgarlik faqat xaridorga tegishli.

Issiq teglar: ponatinib cas 943319-70-8, ishlab chiqaruvchilar, etkazib beruvchilar, zavod, sotib olish, stokda

• Oldingi: 3,4-difluoro-2-((feniltio)metil)benzoy kislotasi CAS 2136287-65-3
• Keyingi2: 3 - yodo - metil - (4 - metilpiperazin - 3 686520 686567567567567565 - 1)